Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)	Common Stock At Market Issuance sales	Common Stock	Additional Paid-In Capital At Market Issuance sales	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	At Market Issuance sales	Total
Balance at Dec. 31, 2023		$ 649		$ 228,203,706	$ 22,243	$ (225,704,176)		$ 2,522,422
Balance (in shares) at Dec. 31, 2023		648,761
Issuance of common stock associated with conversion of debt		$ 9		99,407				99,416
Issuance of common stock associated with conversion of debt (in shares)		9,139
Share-based compensation expense				59,961				59,961
Foreign currency translation adjustment					1,900			1,900
Net loss						(1,915,327)		(1,915,327)
Balance at Mar. 31, 2024		$ 658		228,363,074	24,143	(227,619,503)		768,372
Balance (in Shares) at Mar. 31, 2024		657,900
Balance at Dec. 31, 2024		$ 2,514		238,040,520	45,789	(233,970,752)		4,118,071
Balance (in shares) at Dec. 31, 2024		2,514,499
Issuance of common stock pursuant to At Market Issuance Sales Agreement	$ 657		$ 2,696,885				$ 2,697,542
Issuance of common stock pursuant to At Market Issuance Sales Agreement (in shares)	657,147
Issuance costs associated with sales of common stock pursuant to At Market Issuance Sales Agreement			$ (60,011)				$ (60,011)
Issuance of common stock to vendors		$ 12		29,988				30,000
Issuance of common stock to vendors (in shares)		12,346
Share-based compensation expense				63,599				63,599
Net loss						(3,236,763)		(3,236,763)
Balance at Mar. 31, 2025		$ 3,183		$ 240,770,981	$ 45,789	$ (237,207,515)		$ 3,612,438
Balance (in Shares) at Mar. 31, 2025		3,183,992